Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood. It is an important cause of short and longterm disability. 1, 2 Etiology of the disease is still unknown and it is not a single disease, but a group of related immunoinflammatory and genetically heterogeneous disorders affecting both joints and other structures of the body. 1, 3 JIA is defined as arthritis of unknown etiology that begins before the age of 16, has a disease duration of six weeks or longer and with other known conditions excluded. 4 Although persistent arthritis for at least six weeks is sufficient for the diagnosis, disease duration of at least six months is required before the onset type can be determined. 1 Disease outcomes have improved in recent years, but patients with JIA still have joint destructions and deformities. They also develop rare but important complications like chronic uveitis, blindness, end-stage renal failure secondary to amyloidosis, and growth delay. 5 JIA influences many aspects of a child's life, not only physical, but also social, emotional, educational and economic. 1, 6 Moreover, there has been an increasing interest and need to find new therapies for improving the quality of life for pediatric patients. As a result, many instruments have been developed to assess the health-related quality of life including functional questionnaires which are commonly used to evaluate children with chronic diseases. 3, 7, 8 The Childhood Health Assessment Questionnaire (CHAQ) is one of the most functional and widely used health status instruments in children with JIA. 2 It is a selfreport questionnaire and is said to measure both disability and discomfort in children with chronic arthritis. 3 In this study, we investigated the relationship between CHAQ and types of JIA, the disease activity, laboratory findings, and treatments of patients with JIA. Patients were diagnosed by a pediatric rheumatologist according to the American Rheumatology College criteria, 9, 10 and classified as systemic, polyarticular and oligoarticular based on Durban Criteria. 11 All patients' ages, gender, disease type, age at disease onset, average followup durations and treatment were noted. Active joint involvement and eye examination results were also considered. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and antinuclear antibody values were noted.
PATIENTS AND METHODS
The CHAQ is composed of disability and discomfort indexes. Disability index measures functional ability in eight activities of daily living; dressing and grooming, arising, eating, walking, hygiene, reach, grip and activities. Three components were assessed in each area: 1) the degree to which daily functions were difficult to perform; 2) the use of special aids and devices; and 3) activities for which the assistance of another person was required. Each question had a four level scale between 0 (no difficulty), 1 (with some difficulty), 2 (with much difficulty) and 3 (unable to perform). The category "not applicable" was added for items that might not apply due to the age of the child. Discomfort index assessed pain and overall well-being measured by two 0-100 mm visual analog scales (VASs) (pain VAS and well-being VAS). 2, 3 Higher scores were associated with more severe disease activity. The ESR and CRP values of all patients were noted. ESRs higher than 20 mm/hour and CRPs higher than 1 mg/dL were accepted as elevated. Active disease period was defined according to the 'American Rheumatology College provisional criteria for defining clinical inactive disease protocol'. 12 Active joint involvement, ESR-CRP levels, active systemic involvement features, existence of active uveitis and morning stiffness were noted. 8, 11 Statistical analyses were performed between CHAQ domains and over-all active disease periods and remission periods, and between CHAQ domains and active joint involvement.
Statistical analysis
The SPSS version 17.0 software program (SPSS Inc., Chicago, IL, USA) was used to analyze the data. Results of the descriptive analysis were presented as mean or numbers (n) and percentages (%). All patients' ages, genders, ages at disease onset and control 
RESULTS
Both the JIA group and the healthy group had female predominance. The mean age of the JIA patients was significantly higher than that of the healthy group (p=0.01). The following diagnoses were identified among the participants: oligoarticular JIA (n=38, 46.34%), polyarticular JIA (n=34, 41.46%), and systemic JIA (n=10, 12.2%). Table 1 shows the demographic and clinical characteristics of the patients.
All patients or parents and control groups answered the questionnaire. Two VAS scores for the parent evaluations of pain and overall wellbeing were also calculated. Table 2 demonstrates the scores for eight CHAQ domains of disability index of patients and healthy peers, and Table 3 summarizes the results of the CHAQ and VAS scores for all JIA types. CHAQ clinically discriminated between the healthy group and JIA patients having a higher degree of disability compared to their healthy peers. According to the disease subtypes, there were no statistical differences for VAS, CHAQ scores and overall well-being (p>0.05).
There was no significant difference between the active disease period and subtypes of JIA patients. The number of systemic JIA patients in a remission period was significantly higher than the other types (p=0.22). Table 4 shows the results of the eight CHAQ domains and VAS scores for active disease periods and remission periods. An evaluation of patients for active joint involvement revealed that subjects who had active joint involvement had significantly higher VAS and CHAQ scores compared to those without active joint involvement (p<0.05) ( Table 5) .
Among 82 patients, 67 were receiving therapy. Fifteen of them were on remission without treatment. The first choice for therapy was non-steroidal anti-inflammatory drugs (NSAID) 
DISCUSSION
Juvenile idiopathic arthritis is one of the most common rheumatic diseases of childhood. Children with JIA may have long-term disability and lower quality of life. Consequently, there has been an increasing need to assess the daily functional status and quality of life in JIA. The CHAQ is a modification of the Stanford Health Assessment Questionnaire. More questions were added to CHAQ, so that there is at least one question for each functional area. The CHAQ is a valid and sensitive tool for the evaluation of functional outcomes in children with chronic arthritis. 3 Goycochea-Robles et al. 13 studied 55 patients with JIA and found that the Spanish version of CHAQ was a reliable and valid tool for the assessment of health status in Spanish children. Özdo¤an et al. 14 reported on 85 JIA patients who completed the CHAQ, and showed that the Turkish version of CHAQ was a reliable and valid tool for the functional, physical and psycho-social assessment of children with JIA. This study revealed that the questionnaire has the ability to discriminate between the JIA types and healthy controls, with the systemic and polyarticular types having a higher degree of disability, pain and lower quality of life when compared to the healthy group. Miyamae et al. 3 reported that the disease specific questionnaire had the ability to discriminate between patients with systemic JIA and polyarticular JIA and the control group. Miller et al. 15 also found significantly higher CHAQ scores for patients over the control group. However, they did not find a significant difference between the subtypes of JIA patients. Similar to findings in the literature, in our study, comparison of JIA patients and their healthy peers revealed significantly higher CHAQ results, particularly high disability index, than the control group. In patients with active joint involvement, VAS and CHAQ scores, particularly in daily activities including arising, walking, hygiene, reach and grip were significantly higher than those without active joint involvement. Similarly, Miller et al. 15 reported a higher disability index for patients with active synovitis than the control group.
Erythrocyte sedimentation rate and CRP are two parameters to assess and follow-up disease activity. Their levels may increase in the active disease period. Özdo¤an et al.
14 reported higher ESR levels in systemic and polyarticular type JIA 14 did not evaluate CHAQ scores for the active disease periods and remission periods. The difference is that in our study, we compared the CHAQ scores and disease periods, and showed that patients having an active disease had significantly higher CHAQ and VAS scores than the control group.
Moretti et al. 16 evaluated the CHAQ results of 44 oligoarticular JIA patients before and six months after intra-articular steroid therapy. After six months, CHAQ scores of 23 patients improved, scores of seven patients worsened, and 14 showed no difference. In our study, patients having NSAIDs had better CHAQ evaluations, patients having methotrexate had better VAS scores, and patients having etanercept had better CHAQ and VAS scores than patients who did not receive those therapies. Nevertheless, at this point, it is difficult to say what role these antirheumatic drugs played in CHAQ scores of these children.
Finally, we may conclude that CHAQ is a reliable method for providing real results in JIA follow-up, as clearly reported in the literature. The data from our cross-sectional study revealed that patients having an active disease period had worse CHAQ and VAS scores compared to the control group. Moreover, CHAQ clinically discriminated between the healthy group and JIA patients with a high disability index.
